Search results

Combatting antimicrobial resistance, the UK’s second five-year national action plan promotes optimal use of antimicrobials in humans to ensure safe, effective care by strengthening antimicrobial stewardship programmes. It aims to reduce UK…

Combatting antimicrobial resistance, the UK’s second five-year national action plan continues to promote optimal use of antimicrobials in humans to ensure safe and effective patient care by strengthening antimicrobial stewardship programmes. There…

Background In December 2011, the Department of Health and Social Care (DHSC) set out plans to support the development, adoption and spread of innovation in the NHS. It published a report titled 'Innovation, Health and Wealth, accelerating adoption…

Key findings The comparison of expected uptake to the actual volume of medicines used in the NHS in England is available in the national level medicine groupings interactive dashboard. You can find the dashboard on the online web platform. The…

Introduction This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…

Introduction This section of the report aims to provide users with an evidence-based assessment of the quality of the publication outputs. The quality of the outputs is assessed based on the 9 European Statistical System (ESS) quality dimensions…

Background Innovation scorecard overview The Innovation Scorecard is an action taken from the Department of Health and Social Care's (DHSC) paper titled "Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS" (IHW)…